FDA-issued sodium targets appear to have minimal impact

In 2021, the U.S. Food and Drug Administration (FDA) issued Phase I voluntary sodium reduction targets to encourage manufacturers to lower the amount of sodium in packaged food products by 2024.

Leave a Reply